ENDRA Life Sciences  logo
ENDRA Life Sciences NDRA
$ 3.82 -2.55%

Quarterly report 2025-Q3
added 11-14-2025

report update icon

ENDRA Life Sciences Net Debt 2011-2026 | NDRA

Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]

Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.

Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.

Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.

Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.

Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.

Annual Net Debt ENDRA Life Sciences

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-4.37 M -8.78 M -6.54 M -5.47 M -6.47 M -5.6 M 805 K -19.1 K -156 K - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
805 K -8.78 M -4.07 M

References

  1. Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.

Net Debt of other stocks in the Diagnostics research industry

Issuer Net Debt Price % 24h Market Cap Country
Anixa Biosciences Anixa Biosciences
ANIX
-1.04 M $ 2.85 -3.72 % $ 92.5 K usaUSA
Centogene N.V. Centogene N.V.
CNTG
1.18 M - -6.23 % $ 30.6 M germanyGermany
Agilent Technologies Agilent Technologies
A
1.24 B $ 118.6 0.4 % $ 36.1 B usaUSA
Aspira Women's Health Aspira Women's Health
AWH
-10.9 M - -6.19 % $ 10.5 M usaUSA
Celcuity Celcuity
CELC
82.8 M $ 107.62 -0.63 % $ 4.25 B usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
-53.3 M $ 13.82 -2.68 % $ 418 M usaUSA
Akumin Akumin
AKU
1.21 B - -17.87 % $ 25.9 M canadaCanada
Castle Biosciences Castle Biosciences
CSTL
-108 M $ 27.55 -1.59 % $ 765 M usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
-173 M - - $ 562 M britainBritain
Heska Corporation Heska Corporation
HSKA
-153 M - - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
-11.2 M - -20.0 % $ 1.06 M usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
1.98 B $ 175.77 -1.61 % $ 8.71 B usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
4.63 B $ 108.44 0.16 % $ 8.94 B irlandaIrlanda
IDEXX Laboratories IDEXX Laboratories
IDXX
222 M $ 635.29 -0.22 % $ 51.1 B usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
-33.3 M - -61.36 % $ 2.46 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
-6.07 B - - $ 399 M chinaChina
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
4.74 B $ 283.19 -1.07 % $ 23.6 B usaUSA
Fluidigm Corporation Fluidigm Corporation
FLDM
-5.38 M - 1.08 % $ 308 M usaUSA
Genetic Technologies Limited Genetic Technologies Limited
GENE
-11.1 M - - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
-1.35 B - 0.12 % $ 80.1 M chinaChina
Lantheus Holdings Lantheus Holdings
LNTH
213 M $ 79.15 3.74 % $ 5.34 B usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
769 M - - $ 10.7 B usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
-3.55 M - -34.28 % $ 263 K israelIsrael
Mettler-Toledo International Mettler-Toledo International
MTD
2.06 B $ 1 315.61 -0.56 % $ 27.1 B schweizSchweiz
Biodesix Biodesix
BDSX
14.5 M $ 15.5 -1.59 % $ 2.01 B usaUSA
Myriad Genetics Myriad Genetics
MYGN
115 M $ 5.26 4.89 % $ 487 M usaUSA
NeoGenomics NeoGenomics
NEO
187 M $ 9.53 0.26 % $ 1.22 B usaUSA
Biocept Biocept
BIOC
-11.2 M - -13.05 % $ 7.29 M usaUSA
National Research Corporation National Research Corporation
NRC
30.1 M $ 13.37 -3.47 % $ 328 M usaUSA
Natera Natera
NTRA
-177 M $ 206.39 3.11 % $ 20.3 B usaUSA
Invitae Corporation Invitae Corporation
NVTA
-239 M - - $ 21.2 M usaUSA
BioNano Genomics BioNano Genomics
BNGO
-2.64 M $ 1.12 -1.78 % $ 1.42 M usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
4.92 B $ 208.28 -0.95 % $ 23.1 B usaUSA
Danaher Corporation Danaher Corporation
DHR
14 B $ 204.04 -0.9 % $ 145 B usaUSA
Organovo Holdings Organovo Holdings
ONVO
-10.4 M - -2.3 % $ 19.4 M usaUSA
OPKO Health OPKO Health
OPK
-411 M $ 1.22 -2.02 % $ 847 M usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
-6.67 M $ 1.51 -7.1 % $ 453 M usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
-916 M $ 103.38 0.02 % $ 19.5 B usaUSA
Bioventus Bioventus
BVS
334 M $ 8.8 0.34 % $ 551 M usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
-12.1 M $ 10.3 -4.19 % $ 292 M israelIsrael
DexCom DexCom
DXCM
-842 M $ 73.0 -1.06 % $ 28.5 B usaUSA
PerkinElmer PerkinElmer
PKI
2.3 B - -0.91 % $ 14.7 B usaUSA
Psychemedics Corporation Psychemedics Corporation
PMD
-3.41 M - -1.84 % $ 15.3 M usaUSA
Precipio Precipio
PRPO
-1.18 M $ 24.78 0.38 % $ 32.2 M usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
1.31 B - - $ 10.6 B niderlandNiderland
Quotient Limited Quotient Limited
QTNT
103 M - -11.32 % $ 1.1 M schweizSchweiz
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
-76 M $ 24.01 -4.59 % $ 254 M chinaChina
Illumina Illumina
ILMN
-494 M $ 129.9 -2.25 % $ 20.7 B usaUSA
Renalytix AI plc Renalytix AI plc
RNLX
24.5 K - 5.66 % $ 22.7 M britainBritain
VolitionRx Limited VolitionRx Limited
VNRX
910 K $ 0.2 -0.74 % $ 19.2 M singaporeSingapore